Respiratory Health of Elite Athletes (cold air)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00686491|
Recruitment Status : Completed
First Posted : May 29, 2008
Last Update Posted : February 23, 2011
Eleven National Sports Teams are located in the Quebec Metropolitan Area. In these groups, many athletes are aiming for Olympic medals in Beijing 2008 and Vancouver 2010 Olympic Games. A consultation of the coaches of these National Teams revealed that although a large proportion of these athletes present various cardio-respiratory symptoms, they do not have a rapid access to a systematic medical evaluation and follow-up. Furthermore, little is done in regard to prevention and optimization of treatment of pulmonary and cardiac conditions in the elite athlete's population of the Quebec area.
Cardiorespiratory problems are therefore commonly found in high-level athletes. However, these pathologies are not well characterized in athletes and the associated symptoms often not well perceived. These problems can be serious and it is important to detect them before they appear1 while setting up a systematic medical follow-up. Health professionals should monitor health of the young athletes and help to reduce the risks associated with high level exercise. The following project is an evaluation and follow-up program of high-level athletes, aiming at gathering key-information on long-term effects of high-level training on cardio-respiratory and metabolic parameters. Our aims will be
- to establish a long-term program of systematic evaluation and follow-up of cardiorespiratory health and performance of high elite athletes.
- to evaluate the prevalence of respiratory, circulatory and metabolic problems among high-level athletes
- to evaluate the effects of treatments on cardiorespiratory conditions and exercise performance in athletes who need asthma medication.
|Condition or disease|
|Asthma Cardiovascular Diseases Metabolic Diseases|
|Study Type :||Observational|
|Actual Enrollment :||133 participants|
|Observational Model:||Case Control|
|Official Title:||Center of Excellence in CardioRespiratory Health of High-level Athletes: Evaluation of Long-term Effects of Training.|
|Study Start Date :||June 2007|
|Primary Completion Date :||December 2010|
|Study Completion Date :||December 2010|
Cold air athletes
Other sports elite athletes
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00686491
|Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec|
|Quebec, Canada, G1V4G5|
|Principal Investigator:||Paul POIRIER, MD||Hôpital LAval|